Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania

  • Elizabeth Pisani (Contributor)
  • Adina Nistor (Contributor)
  • Amalia Hasnida (Contributor)
  • Koray Parmaksiz (Contributor)
  • Jingying Xu (Contributor)
  • Maarten Oliver Kok (Contributor)

Dataset

Description

This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in middle income countries, led by Elizabeth Pisani. The full title of the paper is: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
Date made available8-Apr-2019
PublisherHarvard Dataverse

Contact

Cite this